Info

Aushon BioSystems Inc. (Aushon) is a privately-owned corporation developing products and services at the confluence of life science and advanced engineering. Targeting the genomic and proteomic research and diagnostics markets, Aushon's goal is to enable breakthroughs in biological research, diagnostics, drug discovery and the treatment of disease. Aushon's tools and technology will facilitate the realization of personalized medicine using genomic and proteomic signatures. The human genome contains approximately 25,000 genes and the human proteome approximately 1,000,000 protein variants. Most animals and plants of commercial interest have genomes and proteomes of comparable size. A key to future discoveries in life-science, pharmacology and diagnostics is the ability to process genomic and proteomic assays in massively parallel formats; both will be required to unravel the complexities of biological systems and to enable genome-based/proteome-based diagnostics and drug discovery. Microarrays provide the platform for such massively parallel experiments. Microarrays are large collections of tiny biological samples deposited upon a substrate (typically a glass slide), enabling thousands of genomic or proteomic experiments to be performed in parallel. Microarrays of genomic and proteomic materials can be purchased in pre-printed form, or they can be fabricated directly by researchers and scientists using an arrayer - an automated instrument that deposits minute fluid droplets on a substrate. Aushon's products and services include: microarray instrumentation and associated fluid-processing instrumentation; pre-printed microarrays; and custom microarray printing and processing services. Our highly capable and experienced team of scientists, engineers and technicians has been involved in the development of several generations of market-leading, genomic-microarray technology; this experience has now been applied to develop Aushon's enabling proteomic microarray technology and improved genomic microarray products . Aushon's recently-released 2470 Arrayer is an innovative tool that produces high-quality microarrays for DNA, RNA and protein analysis. The 2470 is a user-friendly and highly reliable tool for disease research, drug discovery & development, and molecular diagnostic test development. Aushon BioSystems takes a highly collaborative approach to business relationships with its customers and partners. We are committed to providing our customers with world-class solutions, service and support.